"We know that fatigue is recognized as a late effect of cancer therapy, however this is the first time that survivors of childhood cancer have been examined for fatigue and sleep disturbance problems," says Mulrooney. "Years after these people have been treated for cancer, they are experiencing these problems. Whether this is a result of the cancer or the treatment will be examined in forthcoming studies."
WHAT: The University of Minnesota will present research findings on sleep disturbances in survivors of childhood cancer at the American Society of Clinical Oncology (ASCO) 2003 Annual Meeting
WHO: Daniel Mulrooney, M.D., University of Minnesota Department of Pediatric Hematology and Oncology
WHEN: Saturday, May 31, 2-5:30 p.m.
WHERE: McCormick Place Convention Center, 2301 S. Lake Shore Dr., Chicago, Il